Gara Jalqabaatti › Melanoma › Pennsylvania
Qorannoo klinikaalii Melanoma Pennsylvania keessatti
Qorannoo 47 Melanoma f Pennsylvania keessatti hirmaatuu jiru.
Magaalota Pennsylvania keessatti
Takkalaa qorannoo (Ingiliffa)
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06060613Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- fi 7 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- St. Luke's University Health Network, Easton
- Penn State Health Milton South Hershey Medical Center, Hershey
- Fox Chase Cancer Center, Philadelphia
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06246916DESTINY-PANTUMOUR04
- Research Site, Philadelphia
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Thomas Jefferson University Hospital, Philadelphia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05136196Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Allegheny Health Network, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT05727904A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 25 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07621614Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Fox Chase Cancer Center - East Norriton Hospital Outpatient Center, East Norriton
- UPMC Hillman Cancer Center Erie, Erie
- fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 75 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07068074Pan-tumor MRD Study
- Lancaster General Hospital (UPenn), Lancaster
- Guthrie Foundation, Sayre
- Cancer Care Associates of York (CCAY), York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06605404BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- University of Pennsylvania, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT04752826A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- University of Pittsburgh Medical Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07070232Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT05896839Project: Every Child for Younger Patients With Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- fi 4 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Research Site, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07115043Investigating Real-Time Immunotherapy Symptoms Study
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07280715Tebentafusp-tebn With LDT in Metastatic UM
- Thomas Jefferson University, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ado-2026 · NCT06626516Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT04114136Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT04658303A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05361174MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Fox Chase Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05655312Evaluation of Hypoxia in Primary Melanoma
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT06831071Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT03947385Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
- Fox Chase Cancer Center, Philadelphia
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05498792ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Cam-2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Jefferson Health Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT07015190A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Elb-2026 · NCT06413680A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
- UPenn, Philadelphia
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT06624644A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Elb-2026 · NCT06326411Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT07223424RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06216938A Study of VET3-TGI in Patients With Solid Tumors
- UPMC- Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Elb-2026 · NCT06444815A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Thomas Jefferson University, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin hundi · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- WellSpan Medical Oncology and Hematology, Chambersburg
- fi 13 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06418204Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Thomas Jefferson University Medical Oncology Clinic, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Gur-2026 · NCT05549297Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
- St. Luke's University Health Network, Easton
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT04903119Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
- UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Ama-2026 · NCT06599619Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Penn State Cancer Institute, Hershey
- Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Mud-2025 · NCT03567889Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.